Physician profile
Elena Stadelman
NPI 1528420189
$677.61
in general payments reported to CMS, 2019-2025
10 companies · $51.81 in 2025
The $51.81 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.28 · 2023: $35.02 · 2024: $557 · 2025: $51.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $154.05 | 2024 | Senza |
| Foundation Fusion Solutions, LLC | $143.57 | 2024 | |
| Vertos Medical, INC. | $130.77 | 2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.84 | 2024-2025 | Relistor |
| Abbvie INC. | $50.92 | 2021-2023 | |
| Spr Therapeutics, INC | $29.18 | 2024 | Sprint Pns System |
| Nalu Medical, INC. | $23.11 | 2024 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $18.81 | 2024 | Intracept |
| Medtronic, INC. | $18.38 | 2023 | Intellis Adaptivestim |
| Curonix LLC | $15.98 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Stadelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.